Page last updated: 2024-11-04

vorinostat and Bleb

vorinostat has been researched along with Bleb in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Futakuchi, A1
Inoue, T1
Fujimoto, T1
Kuroda, U1
Inoue-Mochita, M1
Takahashi, E1
Ohira, S1
Tanihara, H1

Other Studies

1 other study available for vorinostat and Bleb

ArticleYear
Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA).
    Investigative ophthalmology & visual science, 2017, 04-01, Volume: 58, Issue:4

    Topics: Angiogenesis Inhibitors; Blister; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen Type

2017